surmount 5 tirzepatide SURMOUNT-5 (NCT05822830) was a multi-center, randomized, open-label, phase 3b trial evaluating the efficacy and safety of #Zepbound® (tirzepatide) compared with #Wegovy® (semaglutide, similar to full dose #ozempic) in adults with obesity + Presented at ECO 2025: In
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2

























![Imperial Rifleman (031) [Promotional Cards] DB3-134](https://cdn.shopify.com/s/files/1/0745/9002/8087/files/533967.jpg?v=1770925441)


